AIP completes $1.27B Avanos acquisition, Avanos to become private at $25 per share
The $25 cash offer creates an immediate premium and arbitrage; close limits further upside, but ensures near-term price realization.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The $25 cash offer creates an immediate premium and arbitrage; close limits further upside, but ensures near-term price realization.
What happened, with direct paths to the underlying reporting
American Industrial Partners has closed its acquisition of Avanos Medical for about $1.272 billion, paying $25 cash per share. Avanos will cease trading on the NYSE and become a private company. The deal provides a cash exit for investors and could refocus Avanos' strategy under new ownership toward accelerating its innovation roadmap.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.